Deucrictibant clinical, real-World, nonclinical, and discovery data to be presented at the Bradykinin Symposium

Pharvaris announced the acceptance of two abstracts for oral presentation and ten abstracts for poster presentation at the upcoming 7th Bradykinin Symposium, to be held from 5-6 September 2024, in Berlin, Germany. Presentation details are as follows:

• Title: Bradykinin Challenge Model in Humanized Bradykinin B2 receptor Transgenic Rat
  Presenter: Jolanta Skarbaliene PhD
  Format: Oral Presentation, Session II
  Date, time: Thursday 5 Sept, 15.05-15.15 CEST (9:05-9:15 am EDT)

• Title: Prophylactic Treatment with Deucrictibant Improves HAE Disease Control and HRQoL
  Presenter: Markus Magerl MD
  Format: Oral Presentation, Session VII
  Date, time: Thursday 5 Sept, 15.05-15.15 CEST (9:05-9:15 am EDT)

• Title: Long-Term Safety and Efficacy of Oral Deucrictibant for HAE Prophylaxis
  Presenter: Marc A. Riedl, MD MS
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: Treatment of HAE Attacks with Oral Deucrictibant: RAPIDe-2 Extension Results
  Presenter: Emel Aygören-Pürsün MD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: Prophylaxis of Hereditary Angioedema Attacks with Oral Deucrictibant: CHAPTER-1 Results
  Presenter: Emel Aygören-Pürsün MD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: Deucrictibant vs. Standard of Care in HAE: Propensity Score-Matched Analysis
  Presenter: Marc A. Riedl, MD MS
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: Clinical Trials Conformity with AURORA COS: a systematic literature review
  Presenter: Remy Petersen, MD PhD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: Cardiovascular safety of repeated oral administration of the B2 receptor antagonist deucrictibant
  Presenter: Nieves Crespo PhD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: The bradykinin challenge model translates across rat, monkey and human
  Presenter: Juan Bravo PhD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: Deucrictibant inhibits carrageenan-induced edema in bradykinin B2 receptor transgenic rat
  Presenter: Anne Lesage PhD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: A novel kinin biomarker assay for characterization of bradykinin-mediated disorders
  Presenter: Evangelia Pardali PhD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

• Title: A HMWK capillary immunoblotting assay to characterize bradykinin-mediated disorders
  Presenter: Evangelia Pardali PhD
  Format: Poster Presentation
  Date, time: Friday 6 Sept, 15.35-16.15 CEST (9:35-10:15 am EDT)

(Source: Pharvaris)